Brief: ADC Therapeutics SA Q3 Sales $13.1 Mln
Nov 2 (Reuters) - ADC Therapeutics SA ADCT.N :
* Q3 SALES 13.1 MILLION USD
Source text for Eikon: ID:nBw2tgcbYa
Further company coverage: ADCT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview